Main > ONCOLOGY (**) > Ovarian Cancer MET Pt-Sensitive R** > Treatment > Co: USA. E. Gemcitabine.HCl Inj.+>

---

Co: USA. E. Gemcitabine.HCl Inj.+>'s subsections
(*) USA 1st Approval Year: 1996
+Carboplatin
>R>6 Months>Pt CT Completion
Company
Patent>Assignee; Claims; No.; Etc
Patent>Total USA No.: 2
Patent>USA Expiration: 2010. 05.15
TradeMark
TradeMark Web-Site

Co: USA. E. Gemcitabine.HCl Inj.+>'s products
This section has no products